Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frankel

Showing results (121-130 of 259) with videos related to

Pageof 26
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodiesW G Laver, W Gerhard, R G Webster, et al.
Cancer Research|March 26, 2002
A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitorsMichaela Feuring-Buske, Arthur E Frankel, Richard L Alexander, et al.
Clinical Pharmacology : Advances and Applications|January 8, 2013
Arginine deprivation therapy for malignant melanomaJung-Ki Yoon, Arthur E Frankel, Lynn G Feun, et al.
Journal of Pediatric Surgery|March 6, 2002
Effective targeted cytotoxicity of neuroblastoma cellsPatrick B Thomas, Stephen J Delatte, Aimee Sutphin, et al.
The Journal of Biological Chemistry|September 9, 1994
Expression of active, processed ricin in transgenic tobaccoP C Sehnke, L Pedrosa, A L Paul, et al.
Protein Engineering|August 31, 2000
Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptorA E Frankel, J Ramage, M Kiser, et al.
Protein and Peptide Letters|July 27, 2002
Peptide toxins directed at the matrix dissolution systems of cancer cellsArthur E Frankel, Thomas H Bugge, Shihui Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemiaArthur E Frankel, Bayard L Powell, Philip D Hall, et al.
Expert Opinion on Biological Therapy|December 17, 2011
Targeting methionine auxotrophy in cancer: discovery & explorationVaidehi Agrawal, Sarah E J Alpini, Everett M Stone, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 29, 2009
Characterization of variant diphtheria toxin-interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trialsYunpeng Su, Shi-Yan Li, Sunil Ghosh, et al.
Pageof 26

Showing results (121-130 of 259) with videos related to

Sort By:
Pageof 26
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Antigenic drift in type A influenza virus: peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodiesW G Laver, W Gerhard, R G Webster, et al.
Cancer Research|March 26, 2002
A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitorsMichaela Feuring-Buske, Arthur E Frankel, Richard L Alexander, et al.
Clinical Pharmacology : Advances and Applications|January 8, 2013
Arginine deprivation therapy for malignant melanomaJung-Ki Yoon, Arthur E Frankel, Lynn G Feun, et al.
Journal of Pediatric Surgery|March 6, 2002
Effective targeted cytotoxicity of neuroblastoma cellsPatrick B Thomas, Stephen J Delatte, Aimee Sutphin, et al.
The Journal of Biological Chemistry|September 9, 1994
Expression of active, processed ricin in transgenic tobaccoP C Sehnke, L Pedrosa, A L Paul, et al.
Protein Engineering|August 31, 2000
Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptorA E Frankel, J Ramage, M Kiser, et al.
Protein and Peptide Letters|July 27, 2002
Peptide toxins directed at the matrix dissolution systems of cancer cellsArthur E Frankel, Thomas H Bugge, Shihui Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemiaArthur E Frankel, Bayard L Powell, Philip D Hall, et al.
Expert Opinion on Biological Therapy|December 17, 2011
Targeting methionine auxotrophy in cancer: discovery & explorationVaidehi Agrawal, Sarah E J Alpini, Everett M Stone, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 29, 2009
Characterization of variant diphtheria toxin-interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trialsYunpeng Su, Shi-Yan Li, Sunil Ghosh, et al.
Pageof 26